Table 1.
Cell line, origin | Down-regulation† | Allele 1/Allele 2‡ |
---|---|---|
U373, astrocytoma | +++ | 001/001 |
HMEC-1, endothelial carcinoma | +++ | 00201–052/00201–052 |
Caco-2, colon carcinoma | +++ | 010/010 |
HT29, colon carcinoma | +++ | 004/016 |
HepG2, liver carcinoma | +++ | 00201–052/00901–049 |
Jurkat, T cell leukaemia | + | 00801–00804/00901–049 |
BJAB, B cell lymphoma | + | 00801–00804/011–047 |
HeLa, cervical carcinoma | − | 00801–00804/00801–00804 |
293T, kidney carcinoma | − | 00801–00804/00801–008 |
†Down-regulation: +++, 50–100%; +, 10–50%; −, 0–10%.
‡MICA allele genotype follows the nomenclature at www.anthonynolan.org.uk. Ambiguous allele assignment, e.g., 00804 not distinguished from 00801, is given as 00801–00804.